Home
Conditions
DNA Virus Infections

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,921 public trials 503 recruiting studies

Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

NCT00353288

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Ancenis, France

GSK Investigational Site Boulogne, France

GSK Investigational Site Dax, France

GSK Investigational Site Draguignan, France

View all 39 locations

View Trial Details

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

NCT00352898

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Edmonton, Alberta, Canada

GSK Investigational Site Vancouver, British Columbia, Canada

GSK Investigational Site Halifax, Nova Scotia, Canada

GSK Investigational Site Enna, Sicily, Italy

View Trial Details

Completed

Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

NCT00335881

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

View all 38 locations

View Trial Details

Completed

Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants

NCT00197275

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +25 more
Locations: GSK Investigational Site Bangkok, Thailand

GSK Investigational Site Khon Kaen, Thailand

GSK Investigational Site Songkhla, Thailand

View Trial Details

Completed

Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis

NCT00438022

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, +18 more
Locations: University of Bonn, Germany Bonn, Germany

View Trial Details

Completed

Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules

NCT00316147

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +36 more
Locations: GSK Investigational Site Bangalore, India

GSK Investigational Site Baroda, India

GSK Investigational Site Goā, India

GSK Investigational Site New Delhi, India

View Trial Details

Completed

Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years

NCT00290277

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: GSK Investigational Site Daegu, South Korea

GSK Investigational Site Kwangju, South Korea

GSK Investigational Site Seoul, South Korea

GSK Investigational Site Seoul, South Korea

View Trial Details

Completed

Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

NCT00329576

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Wilrijk, Belgium

GSK Investigational Site Munich, Bavaria, Germany

GSK Investigational Site Basel, Switzerland

View Trial Details

Completed

Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib

NCT00332566

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site Capital Federal, Buenos Aires, Argentina

GSK Investigational Site León, Nicaragua

View Trial Details

Completed

Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT

NCT02201420

Conditions: DNA Virus Infections, Herpesviridae Infections, Infections, +8 more
Locations: San Francisco General Hospital San Francisco, California, United States

View Trial Details

DNA Virus Infections

DNA Virus Infections trial results

Related conditions